85 related articles for article (PubMed ID: 19551366)
1. Use of primary human cells in high-throughput screens.
Dunne A; Jowett M; Rees S
Methods Mol Biol; 2009; 565():239-57. PubMed ID: 19551366
[TBL] [Abstract][Full Text] [Related]
2. Introduction: cell-based assays for high-throughput screening.
An WF; Tolliday NJ
Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of uniform-well readouts.
Josiah S
Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
5. Statistics and decision making in high-throughput screening.
Coma I; Herranz J; Martin J
Methods Mol Biol; 2009; 565():69-106. PubMed ID: 19551358
[TBL] [Abstract][Full Text] [Related]
6. Design and implementation of high-throughput screening assays.
Macarrón R; Hertzberg RP
Methods Mol Biol; 2009; 565():1-32. PubMed ID: 19551355
[TBL] [Abstract][Full Text] [Related]
7. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
8. High-throughput siRNA-based functional target validation.
Xin H; Bernal A; Amato FA; Pinhasov A; Kauffman J; Brenneman DE; Derian CK; Andrade-Gordon P; Plata-Salamán CR; Ilyin SE
J Biomol Screen; 2004 Jun; 9(4):286-93. PubMed ID: 15191645
[TBL] [Abstract][Full Text] [Related]
9. Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
Joesch C; Guevarra E; Parel SP; Bergner A; Zbinden P; Konrad D; Albrecht H
J Biomol Screen; 2008 Mar; 13(3):218-28. PubMed ID: 18270364
[TBL] [Abstract][Full Text] [Related]
10. Process validation and screen reproducibility in high-throughput screening.
Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
[TBL] [Abstract][Full Text] [Related]
11. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
Crisman TJ; Jenkins JL; Parker CN; Hill WA; Bender A; Deng Z; Nettles JH; Davies JW; Glick M
J Biomol Screen; 2007 Apr; 12(3):320-7. PubMed ID: 17438067
[TBL] [Abstract][Full Text] [Related]
12. Streamlining lead discovery by aligning in silico and high-throughput screening.
Davies JW; Glick M; Jenkins JL
Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening: update on practices and success.
Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
[TBL] [Abstract][Full Text] [Related]
14. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
[TBL] [Abstract][Full Text] [Related]
15. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells.
Yauch RL; Kadel EE; Nicholas C; Tetangco S; Clary DO
J Biomol Screen; 2004 Dec; 9(8):704-11. PubMed ID: 15634797
[TBL] [Abstract][Full Text] [Related]
17. Human cell systems for drug discovery.
Horrocks C; Halse R; Suzuki R; Shepherd PR
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):570-5. PubMed ID: 12951820
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel keratinocyte differentiation modulating compounds by high-throughput screening.
Honma M; Stubbs M; Collins I; Workman P; Aherne W; Watt FM
J Biomol Screen; 2006 Dec; 11(8):977-84. PubMed ID: 17092913
[TBL] [Abstract][Full Text] [Related]
19. The role of computational methods in the identification of bioactive compounds.
Glick M; Jacoby E
Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
[TBL] [Abstract][Full Text] [Related]
20. Assay technologies for screening ion channel targets.
Mattheakis LC; Savchenko A
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
